PF-Atlas › Drugs › PMFF-Net AI Diagnostic

PMFF-Net AI Diagnostic

Idiopathic Pulmonary Fibrosis · Parallel Multi-scale Feature Fusion Network classifies ILD patterns from CT with 97.6% accuracy

Mechanism
Parallel Multi-scale Feature Fusion Network classifies ILD patterns from CT with 97.6% accuracy
Development stage
Available Now
Evidence level
Computational
Developer
Multiple

Overview

Transformer+CNN hybrid architecture. Diagnoses UIP pattern, NSIP, and other ILD subtypes. Enables earlier treatment initiation. Reduces diagnostic delay from years to minutes.

Medical disclaimer. This page summarizes research about PMFF-Net AI Diagnostic for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.